申请人:Murugesan Natesan
公开号:US20050043339A1
公开(公告)日:2005-02-24
Compounds having the formula,
enantiomers, diastereomers, solvates and salts thereof, where R
1
, R
2
, R
3
, R
4
, A, X, and J are described herein, are inhibitors of calcium channel function, and are useful in treating calcium channel-dependent disorders, including hypertension.
具有以下公式、对映异构体、非对映异构体、溶剂合物和盐的化合物,其中R1、R2、R3、R4、A、X和J如本文所述,是钙通道功能抑制剂,可用于治疗钙通道依赖性疾病,包括高血压。